|
?:authorAffiliation
|
-
[\'The China-Singapore (Chongqing) Demonstration Initiative on Strategic Connectivity Think Tank, Chongqing 400043, China; Institute for Health Innovation and Technology (iHealthtech), National University of Singapore, Singapore 119077, Singapore.\', \'The First People\'s Hospital of Chongqing Liang Jiang New Area, Chongqing, China.\', \'Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, Canada.\', \'Department of Neurology, Daping Hospital, Army Medical University, Chongqing 400042, China.\', \'Faculty of Education, Huaibei Normal University, Huaibei 235000, China; Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119077, Singapore.\', \'Institute for Health Innovation and Technology (iHealthtech), National University of Singapore, Singapore 119077, Singapore; Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119077, Singapore. Electronic address: pcmrhcm@nus.edu.sg.\', \'Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA; Institute for Preventive Medicine and Public Health, Hanoi Medical University, Hanoi 100000, Viet Nam.\', \'Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119077, Singapore; Department of Psychological Medicine, National University Health System, Singapore.\', \'Alice Lee Centre for Nursing Studies, National University of Singapore, Singapore.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}